Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-231-4
CAS number: 1314-35-8
to Column 2 of REACH Annex X, a carcinogenicity study may be required if
the substance has a widespread dispersive use, or there is evidence of
frequent or long-term human exposure and the substance is classified as
mutagen category 3, or there is evidence from the repeated dose
study(ies) that the substance is able to induce hyperplasia and/or
pre-neoplastic lesions. Based on the available data, tungsten trioxide
would not classify as a mutagen. No hyperplasia and/or pre-neoplastic
lesions were identified in a 28-day repeat dose inhalation toxicity
study on tungsten oxide, which was used for read-across. Therefore, a
carcinogenicity study is not required under REACH.
No carcinogenicity data are available for tungsten trioxide. Therefore,
classification cannot be made due to lack of data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again